These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37160248)

  • 1. Prodrug approaches for the development of a long-acting drug delivery systems.
    Chien ST; Suydam IT; Woodrow KA
    Adv Drug Deliv Rev; 2023 Jul; 198():114860. PubMed ID: 37160248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer Delivery Systems for Long-Acting Antiretroviral Drugs.
    Nayan MU; Panja S; Sultana A; Zaman LA; Vora LK; Sillman B; Gendelman HE; Edagwa B
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension.
    Mertz N; Larsen SW; Kristensen J; Østergaard J; Larsen C
    J Pharm Sci; 2016 Oct; 105(10):3079-3087. PubMed ID: 27475785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in prodrugs as drug delivery systems.
    Lin C; Sunkara G; Cannon JB; Ranade V
    Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances on Cellulose-Based Nano-Drug Delivery Systems: Design of Prodrugs and Nanoparticles.
    Dai L; Si C
    Curr Med Chem; 2019; 26(14):2410-2429. PubMed ID: 28699504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of small-molecule prodrugs.
    Fralish Z; Chen A; Khan S; Zhou P; Reker D
    Nat Rev Drug Discov; 2024 May; 23(5):365-380. PubMed ID: 38565913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials.
    Nguyen A; Böttger R; Li SD
    Biomaterials; 2021 Aug; 275():120955. PubMed ID: 34130143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.
    Vemula PK; Wiradharma N; Ankrum JA; Miranda OR; John G; Karp JM
    Curr Opin Biotechnol; 2013 Dec; 24(6):1174-82. PubMed ID: 23465753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations.
    Yoshida T; Kojima H
    Mol Pharm; 2023 Nov; 20(11):5312-5331. PubMed ID: 37856863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy agent-unsaturated fatty acid prodrugs and prodrug-nanoplatforms for cancer chemotherapy.
    Sun B; Luo C; Cui W; Sun J; He Z
    J Control Release; 2017 Oct; 264():145-159. PubMed ID: 28844757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acids as promoieties in prodrug design and development.
    Vig BS; Huttunen KM; Laine K; Rautio J
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained Intracellular Raltegravir Depots Generated with Prodrugs Designed for Nanoparticle Delivery.
    Creighton RL; Suydam IT; Ebner ME; Afunugo WE; Bever AM; Cao S; Jiang Y; Woodrow KA
    ACS Biomater Sci Eng; 2019 Aug; 5(8):4013-4022. PubMed ID: 33117884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation and Controlled Release of a Camptothecin Prodrug from Nanocarriers and Microgels: Tuning Release Rate with Nanocarrier Excipient Composition.
    Wilson BK; Sinko PJ; Prud'homme RK
    Mol Pharm; 2021 Mar; 18(3):1093-1101. PubMed ID: 33440941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid prodrug nanocarriers in cancer therapy.
    Mura S; Bui DT; Couvreur P; Nicolas J
    J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
    J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between the linker and polymer molecular weight of a self-assembling prodrug on the pharmacokinetics and therapeutic efficacy.
    Nguyen A; Rouhollahi E; Böttger R; Ong CY; Chao PH; Wu J; Chen Y; Li SD
    Biomater Sci; 2022 Jun; 10(12):3122-3136. PubMed ID: 35544350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
    Su FY; Srinivasan S; Lee B; Chen J; Convertine AJ; West TE; Ratner DM; Skerrett SJ; Stayton PS
    J Control Release; 2018 Oct; 287():1-11. PubMed ID: 30099019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.